Clinical Trials
6 trialsNCT02834013 2026-06-03
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06399757 2026-01-07
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Apollo Therapeutics Ltd
Phase 1/2 Recruiting
NCT04665921 2025-02-07
A Study of SGN-STNV in Advanced Solid Tumors
Seagen Inc.
Phase 1 Terminated
NCT06182644 2024-01-22
FAPI
Guangdong Provincial People's Hospital
Phase NA Unknown
NCT04088786 2022-05-06
Phase I Trial HIPEC With Nal-irinotecan
Stony Brook University
Phase 1 Completed
NCT01037049 2018-09-17
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Phase 2 Unknown